FYI: When a Danish pharmaceuticals giant was accused of fraud, securities litigator Irwin Schwartz knew who’d pay the price: Novo Nordisk shareholders. Many of them happened to be his clients.
Attorneys and financiers smell opportunity when a corporate scandal breaks and the company’s stock plunges. If major shareholders sue the company for losses and win, the awards can be massive. Schwarz represents such shareholders — pension funds and other institutional investors with vast global stock portfolios, which inevitably own stakes in most major public companies.
Regards,
Ted
